Prevalidation of salivary biomarkers for oral cancer detection

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 4, 2012, Pages 664-672

  Elashoff, David ^a   Zhou, Hui ^b   Reiss, Jean ^a   Wang, Jianghua ^b   Xiao, Hua ^b   Henson, Bradley ^b   Hu, Shen ^b   Arellano, Martha ^b   Sinha, Uttam ^c   Le, Anh ^d   Messadi, Diana ^b   Wang, Marilene ^a   Nabili, Vishad ^a   Lingen, Mark ^e   Morris, Darly ^f   Randolph, Timothy ^f   Feng, Ziding ^f   Akin, David ^b   Kastratovic, Dragana A ^g   Chia, David ^a   Abemayor, Elliot ^a   Wong, David T W ^a,b   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Dental Research Institute   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; MESSENGER RNA; TUMOR MARKER;

ADULT; ARTICLE; CANCER DIAGNOSIS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SALIVA ANALYSIS; SALIVARY GLAND; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SUBCUTANEOUS FAT;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INTERLEUKIN-8; LOS ANGELES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, MESSENGER; SALIVA; TUMOR MARKERS, BIOLOGICAL;

EID: 84859382029     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-1093     Document Type: Article

References (21)

1. Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc 2010;141:509-20.
2. Dowling P, Wormald R, Meleady P, Henry M, Curran A, Clynes M. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J Proteomics 2008;71:168-75. (Pubitemid 351915861)
3. Franzmann EJ, Reategui EP, Carraway KL, Hamilton KL, Weed DT, Goodwin WJ. Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev 2005;14: 735-9. (Pubitemid 40489225)
4. Houali K,Wang X, Shimizu Y, Djennaoui D, Nicholls J, Fiorini S, et al. A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin Cancer Res 2007;13:4993-5000. (Pubitemid 47502063)
5. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008;14:6246-52.
6. Nagler R, Bahar G, Shpitzer T, Feinmesser R. Concomitant analysis of salivary tumor markers-a new diagnostic tool for oral cancer. Clin Cancer Res 2006;12:3979-84. (Pubitemid 44078083)
7. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004;10:8442-50. (Pubitemid 40053408)
8. Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, et al. Promoter hypermethylation patterns of p16, O6-methylguanine- DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001;61:939-42. (Pubitemid 32174408)
9. Spafford MF, Koch WM, Reed AL, Califano JA, Xu LH, Eisenberger CF, et al. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res 2001;7:607-12. (Pubitemid 32707986)
10. Franzmann EJ, Lundy DS, Abitbol AA, Goodwin WJ. Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiation for advanced head and neck cancer. Head Neck 2006;28:663-70. (Pubitemid 44116890)
11. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, et al. Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome. Arthritis Rheum 2007;56:3588-600. (Pubitemid 350100692)
12. Li Y, Zhou X, St John MA, Wong DT. RNA profiling of cell-free saliva using microarray technology. J Dent Res 2004;83: 199-203. (Pubitemid 41715238)
13. Hu Z, Zimmermann BG, Zhou H, Wang J, Henson BS, Yu W, et al. DTW Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids. Clin Chem 2008;54:824-32. (Pubitemid 351671599)
14. Ulmer TA, Keeler V, Loh L, Chibbar R, Torlakovic E, Andre S, et al. Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer. J Cell Biochem 2006;98:1351-66. (Pubitemid 44128371)
15. Park YP, Choi SC, Kim JH, Song EY, Kim JW, Yoon DY, et al. Upregulation of Mac-2 binding protein by hTERT in gastric cancer. Int J Cancer 2007;120:813-20. (Pubitemid 46175401)
16. Marchetti A, Tinari N, Buttitta F, Chella A, Angeletti CA, Sacco R, et al. Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Res 2002;62:2535-9. (Pubitemid 34462731)
17. Wu CC, Chien KY, Tsang NM, Chang KP, Hao SP, Tsao CH, et al. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics 2005;5:3173-82. (Pubitemid 41176485)
18. Cooper H, Hedges L. The handbook of research synthesis. New York: Russell Sage Foundation; 1994.
19. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003;49:1-6. (Pubitemid 36078546)
20. Gao K, Zhou H, Zhang L, Lee JW, Zhou Q, Hu S, et al. Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer. PLoS One 2009;4:e5875.
21. Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst 2008;100:1432-8.